KA
BIIB icon

Kovack Advisors’s Biogen BIIB Stock Holding History

Kovack Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-781
Closed -$214K – 440
2018
Q1 		$214K Sell
781
-157
-17% -$48.7K 0.05% 409
2017
Q4 		$272K Buy
+938
New +$301K 0.07% 324
2015
Q2 		– Sell
-594
Closed -$251K – 219
2015
Q1 		$251K Sell
594
-64
-10% -$25.2K 0.21% 124
2014
Q4 		$223K Buy
+658
New +$213K 0.23% 117

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kovack Advisors's BIIB Position: Q2 2018 in Review

Kovack Advisors sold out of Biogen (BIIB) in Q2 2018, closing a stake of 781 shares — an estimated $214K sold.

Kovack Advisors first reported a position in BIIB in Q4 2014 and held it in 4 quarters. The position peaked at $272K in Q4 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Kovack Advisors reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Kovack Advisors sold 781 Biogen shares in Q2 2018, an estimated $214K.
  • Kovack Advisors first reported a position in Biogen in Q4 2014 and held it in 4 quarters.
  • Kovack Advisors's Biogen position peaked at $272K in Q4 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Kovack Advisors's 13F filing for Q2 2018, filed 1 Aug 2018.